Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion type Assertion NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_head.
- NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion description "[KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_provenance.
- NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion evidence source_evidence_literature NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_provenance.
- NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion SIO_000772 21844874 NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_provenance.
- NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion wasDerivedFrom befree-20140225 NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_provenance.
- NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_assertion wasGeneratedBy ECO_0000203 NP933473.RAWjHaVrXci52LKCGXQpIruL362VkURaYJfC-fVHW5dRw130_provenance.